Biomet boosted by hip and knee sales in strong Q4
This article was originally published in Clinica
Executive Summary
Biomet has witnessed a strong end to fiscal 2010 after sales of its hip and knee products helped the firm record a 10% revenue growth and narrow its net loss for the fourth quarter.